Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient
Franco-Luzon et al.
Cancers
April 2020
Authors and Affiliates
Lidia Franco-Luzón 1, Sandra García-Mulero 2 3, Rebeca Sanz-Pamplona 3, Gustavo Melen 4 5, David Ruano 5, Álvaro Lassaletta 5, Luís Madero 1 5 6, África González-Murillo 4 5, Manuel Ramírez 4 5; 1Children Oncohematology Foundation, 28079 Madrid, Spain.
2Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.
3Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
4Biomedical Research Foundation, Niño Jesús Children Hospital, 28009 Madrid, Spain.
5La Princesa Institute of Health Research, 28006 Madrid, Spain.
6Oncohematology Unit, Hospital Infantil Universitario Niño Jesús, 28009 Madrid, Spain.